Dose-dense cisplatin/paclitaxel: a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer

FE Jongh, Ronald de Wit, Jaap Verweij, A Sparreboom, Martin van den Bent, Gerrit Stoter, MEL Burg

Research output: Contribution to journalArticleAcademicpeer-review

38 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2005-2013
Number of pages9
JournalEuropean Journal of Cancer
Volume38
DOIs
Publication statusPublished - 2002

Cite this